1
|
Rajagopal S, Yao X, Abadir W, Baetz TD, Easson AM, Knight G, McWhirter E, Nessim C, Rosen CF, Sun A, Wright FC, Petrella TM. An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent. Clin Oncol (R Coll Radiol) 2024; 36:243-253. [PMID: 38336503 DOI: 10.1016/j.clon.2024.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 12/20/2023] [Accepted: 01/15/2024] [Indexed: 02/12/2024]
Abstract
AIMS To make recommendations on managing the surveillance of patients with stage I, II, III or resectable IV melanoma who are clinically free of disease following treatment with curative intent. MATERIALS AND METHODS This guideline was developed by Ontario Health's (Cancer Care Ontario's) Program in Evidence-Based Care and the Melanoma Disease Site Group (including seven medical oncologists, four surgical oncologists, three dermatologists, one radiation oncologist and one patient representative). The MEDLINE, EMBASE, Cochrane Library, PROSPERO databases and the main relevant guideline websites were searched. Internal and external reviews were conducted, with final approval by the Program in Evidence-Based Care and the Melanoma Disease Site Group. The Grading of Recommendations, Assessment, Development and Evaluation approach was followed, and the Modified Delphi method was used. RESULTS Based on the current evidence (eight eligible original study papers and four relevant guidelines) and the clinical opinions of the authors of this guideline, the initial recommendations were made. To reach 75% agreement for each recommendation, the Melanoma Disease Site Group (16 members) voted twice and one recommendation was voted on three times. After a comprehensive internal and external review process (including national and international reviewers), 12 recommendations, three weak recommendations and six qualified statements were ultimately made. CONCLUSIONS After a systematic review, a comprehensive internal and external review process and a consensus process, the current guideline has been created. The guideline authors believe that this guideline will help clinicians, patients and policymakers make well-informed healthcare decisions that will guide them in clinical melanoma surveillance and ultimately assist in improving patient outcomes.
Collapse
Affiliation(s)
- S Rajagopal
- Trillium Health Partners, Credit Valley Hospital, Peel Regional Cancer Centre, Mississauga, Ontario, Canada.
| | - X Yao
- Department of Oncology, Department of Health Research Methods Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Program in Evidence-Based Care, Ontario Health (Cancer Care Ontario), Hamilton, Ontario, Canada.
| | - W Abadir
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, Ontario, Canada
| | - T D Baetz
- Cancer Centre of Southeastern Ontario, Queen's Cancer Research Institute, Kingston, Ontario, Canada
| | - A M Easson
- Department of Surgery, Marvelle Koffler Breast Centre, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - G Knight
- Department of Oncology, Grand River Regional Cancer Centre, Grand River Hospital, Kitchener, Ontario, Canada
| | - E McWhirter
- Department of Medical Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada
| | - C Nessim
- Department of Surgery, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada
| | - C F Rosen
- Division of Dermatology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
| | - A Sun
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - F C Wright
- Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
| | - T M Petrella
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
| |
Collapse
|
2
|
Talwar A, Varghese J, Knight G, Katariya N, Caicedo-Ramirez J, Dietch Z, Borja-Cacho D, Ladner D, Christopher D, Baker T, Abecassis M, Mouli S, Desai K, Riaz A, Thornburg B, Salem R. Abstract No. 184 Pre-operative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic, obliterative portal vein thrombosis: outcomes following liver transplantation. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
3
|
Cheung W, Samimi S, Kassam S, Colwell B, Meyer P, Knight G, Ma K, Eberg M, Mancini J, Alemayehu M, Martinez D, Packalen M, Wani R, Ngan E, Du Y, Inam N. P-28 Real-world observational study of MVASI in metastatic colorectal cancer patients in Canada: Baseline patient characteristics. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
4
|
Knight G, Myers B, Banzal R, Leighton R. P.121 Acute consumptive coagulopathy in a SARS-CoV-2 positive patient. Int J Obstet Anesth 2021. [PMCID: PMC8186981 DOI: 10.1016/j.ijoa.2021.103119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
5
|
Beardsley A, Knight G, Hohlastos E, Lewandowski R, Salem R, Mouli S. 3:45 PM Abstract No. 67 Prostate artery embolization with Bead Block microspheres for lower urinary tract symptoms from benign prostatic hyperplasia: Interim Results from a prospective FDA-Approved Investigational Device Exemption Study. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
6
|
Abstract
The thermal dissociation reaction CF3 (+Ar) → CF2 + F (+Ar) was studied in incident and reflected shock waves by monitoring UV absorption signals of the primary dissociation product CF2. CF3 radicals were produced by thermal decomposition of CF3I. Accounting for secondary reactions of F atoms, rate constants for the unimolecular dissociation were derived. Experimental parts of the falloff curves were obtained over the ranges 1544-2106 K and 1.0 × 10-5 ≤ [Ar] ≤ 9.3 × 10-5 mol cm-3. Theoretical modeling allowed for a construction of the full falloff curves connecting the limiting low-pressure rate constants k0 = [Ar] 2.5 × 1018 (T/2000 K)-5.1 exp (-42 450 K/T) cm3 mol-1 s-1 with the limiting high-pressure rate constants k∞ = 1.6 × 1016 (T/2000 K)-1.3 exp (-43 250 K/T) s-1 (center broadening factors of Fcent = 0.25, 0.22, and 0.20 at 1500, 2000, and 2500 K, respectively, were used). The influence of simplifications of falloff expressions and of limiting rate constants on the representation of experimental data is discussed.
Collapse
Affiliation(s)
- C J Cobos
- INIFTA, Facultad de Ciencias Exactas, Universidad Nacional de La Plata , CONICET , Casilla de Correo 16, Sucursal 4 , La Plata 1900 , Argentina
| | - G Knight
- Edwards Innovation Centre , Clevedon BS21 6TH , U.K
| | - L Sölter
- Institut für Physikalische Chemie , Universität Göttingen , Tammannstrasse 6 , D-37077 Göttingen , Germany
| | - E Tellbach
- Institut für Physikalische Chemie , Universität Göttingen , Tammannstrasse 6 , D-37077 Göttingen , Germany
| | - J Troe
- Institut für Physikalische Chemie , Universität Göttingen , Tammannstrasse 6 , D-37077 Göttingen , Germany.,Max-Planck-Institut für Biophysikalische Chemie , Am Fassberg 11 , D-37077 Göttingen , Germany
| |
Collapse
|
7
|
Petrella TM, Fletcher GG, Knight G, McWhirter E, Rajagopal S, Song X, Baetz TD. Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline. Curr Oncol 2020; 27:e43-e52. [PMID: 32218667 PMCID: PMC7096195 DOI: 10.3747/co.27.5933] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Background Previous versions of the guideline from the Program in Evidence-Based Care (pebc) at Ontario Health (Cancer Care Ontario) recommended that the use of high-dose interferon alfa 2b therapy be discussed and offered to patients with resected cutaneous melanoma with a high risk of recurrence. Subsequently, several clinical trials in patients with resected or metastatic melanoma found that immune checkpoint inhibitors and targeted therapies have a benefit greater than that with interferon. It was therefore considered timely for an update to the guideline about adjuvant systemic therapy in melanoma. Methods The present guideline was developed by the pebc and the Melanoma Disease Site Group (dsg). Based on a systematic review from a literature search conducted using medline, embase, and the Evidence Based Medicine Reviews databases for the period 1996 to 28 May 2019, the Working Group drafted recommendations. The systematic review and recommendations were then circulated to the Melanoma dsg and the pebc Report Approval Panel for internal review; the revised document underwent external review. Recommendations For patients with completely resected cutaneous or mucosal melanoma with a high risk of recurrence, the recommended adjuvant therapies are nivolumab, pembrolizumab, or dabrafenib-trametinib for patients with BRAF V600E or V600K mutations; nivolumab or pembrolizumab are recommend for patients with BRAF wild-type disease. Use of ipilimumab is not recommended. Molecular testing should be conducted to help guide treatment decisions. Interferon alfa, chemotherapy regimens, vaccines, levamisole, bevacizumab, bacillus Calmette-Guérin, and isolated limb perfusion are not recommended for adjuvant treatment of cutaneous melanoma except as part of a clinical trial.
Collapse
Affiliation(s)
- T M Petrella
- University of Toronto and Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
| | - G G Fletcher
- Program in Evidence-Based Care, Ontario Health (Cancer Care Ontario), and Department of Oncology, McMaster University, Hamilton, ON
| | - G Knight
- Department of Oncology, McMaster University, Hamilton, and Grand River Regional Cancer Centre, Kitchener, ON
| | - E McWhirter
- Department of Oncology, Division of Medical Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON
| | | | - X Song
- Department of Internal Medicine, Division of Medical Oncology, University of Ottawa, and The Ottawa Hospital Cancer Centre, Ottawa, ON
| | - T D Baetz
- Department of Oncology, Queen's University, and Cancer Centre of Southeastern Ontario-Kingston General Hospital, Kingston, ON
| |
Collapse
|
8
|
Cobos CJ, Knight G, Sölter L, Tellbach E, Troe J. Experimental and modelling study of the multichannel thermal dissociations of CH3F and CH2F. Phys Chem Chem Phys 2018; 20:2627-2636. [DOI: 10.1039/c7cp07098e] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The thermal unimolecular dissociation of CH3F was studied in shock waves by monitoring the UV absorption of a dissociation product identified as CH2F.
Collapse
Affiliation(s)
- C. J. Cobos
- INIFTA
- Facultad de Ciencias Exactas
- Universidad Nacional de La Plata
- CONICET
- Casilla de Correo 16
| | | | - L. Sölter
- Institut für Physikalische Chemie
- Universität Göttingen
- D-37077 Göttingen
- Germany
| | - E. Tellbach
- Institut für Physikalische Chemie
- Universität Göttingen
- D-37077 Göttingen
- Germany
| | - J. Troe
- Institut für Physikalische Chemie
- Universität Göttingen
- D-37077 Göttingen
- Germany
- Max-Planck-Institut für Biophysikalische Chemie
| |
Collapse
|
9
|
Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: a clinical practice guideline. ACTA ACUST UNITED AC 2017; 24:324-331. [PMID: 29089800 DOI: 10.3747/co.24.3736] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND Resection is the cornerstone of cure for gastric adenocarcinoma; however, several aspects of surgical intervention remain controversial or are suboptimally applied at a population level, including staging, extent of lymphadenectomy (lnd), minimum number of lymph nodes that have to be assessed, gross resection margins, use of minimally invasive surgery, and relationship of surgical volumes with patient outcomes and resection in stage iv gastric cancer. METHODS Literature searches were conducted in databases including medline (up to 10 June 2016), embase (up to week 24 of 2016), the Cochrane Library and various other practice guideline sites and guideline developer Web sites. A practice guideline was developed. RESULTS One guideline, seven systematic reviews, and forty-eight primary studies were included in the evidence base for this guidance document. Seven recommendations are presented. CONCLUSIONS All patients should be discussed at a multidisciplinary team meeting, and computed tomography (ct) imaging of chest and abdomen should always be performed when staging patients. Diagnostic laparoscopy is useful in the determination of M1 disease not visible on ct images. A D2 lnd is preferred for curative-intent resection of gastric cancer. At least 16 lymph nodes should be assessed for adequate staging of curative-resected gastric cancer. Gastric cancer surgery should aim to achieve an R0 resection margin. In the metastatic setting, surgery should be considered only for palliation of symptoms. Patients should be referred to higher-volume centres and those that have adequate support to manage potential complications. Laparoscopic resections should be performed to the same standards as those for open resections, by surgeons who are experienced in both advanced laparoscopic surgery and gastric cancer management.
Collapse
Affiliation(s)
| | - R Cosby
- Program in Evidence-Based Care, Department of Oncology, McMaster University, Hamilton
| | - L Klein
- Humber River Regional Hospital, Toronto
| | - G Knight
- Grand River Regional Cancer Centre, Kitchener
| | | | | | | | - J Ringash
- Princess Margaret Hospital, Toronto, ON
| |
Collapse
|
10
|
Cobos CJ, Knight G, Sölter L, Tellbach E, Troe J. Shock Wave and Theoretical Modeling Study of the Dissociation of CH2F2. II. Secondary Reactions. J Phys Chem A 2017; 121:7820-7826. [DOI: 10.1021/acs.jpca.7b05857] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C. J. Cobos
- INIFTA,
Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CONICET, Casilla de Correo 16, Sucursal 4, 1900 La Plata, Argentina
| | - G. Knight
- Edwards Innovation Centre, Clevedon BS21 6 TH, U.K
| | - L. Sölter
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
| | - E. Tellbach
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
| | - J. Troe
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
- Max-Planck-Institut für Biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Germany
| |
Collapse
|
11
|
Cobos CJ, Knight G, Sölter L, Tellbach E, Troe J. Kinetic and Spectroscopic Studies of the Reaction of CF2 with H2 in Shock Waves. J Phys Chem A 2017; 121:7827-7834. [DOI: 10.1021/acs.jpca.7b05859] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- C. J. Cobos
- INIFTA,
Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CONICET, Casilla de Correo 16, Sucursal 4, 1900 La Plata, Argentina
| | - G. Knight
- Edwards Innovation Centre, Clevedon BS21 6TH, U.K
| | - L. Sölter
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
| | - E. Tellbach
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
| | - J. Troe
- Institut
für Physikalische Chemie, Universität Göttingen, Tammannstrasse
6, D-37077 Göttingen, Germany
- Max-Planck-Institut für Biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Germany
| |
Collapse
|
12
|
|
13
|
Yousif A, Mohamed BA, Karsani M, A/Gadir T, A/Rahman AM, Siddig H, Knight G, Ibrahim ZO, Khalid KM, F/Almola YF. Types of Haemoglobin in Patients Attending Khartoum Teaching Hospital - Sudan. Sud Jnl Med Sci 2007. [DOI: 10.4314/sjms.v2i1.38465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
14
|
Nguyen HT, King LM, Knight G. Real-time head movement system and embedded Linux implementation for the control of power wheelchairs. Conf Proc IEEE Eng Med Biol Soc 2007; 2004:4892-5. [PMID: 17271409 DOI: 10.1109/iembs.2004.1404353] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Mobility has become very important for our quality of life. A loss of mobility due to an injury is usually accompanied by a loss of self-confidence. For many individuals, independent mobility is an important aspect of self-esteem. Head movement is a natural form of pointing and can be used to directly replace the joystick whilst still allowing for similar control. Through the use of embedded LINUX and artificial intelligence, a hands-free head movement wheelchair controller has been designed and implemented successfully. This system provides for severely disabled users an effective power wheelchair control method with improved posture, ease of use and attractiveness.
Collapse
Affiliation(s)
- H T Nguyen
- Key University Research Centre for Health Technology, Technology University, Sydney, NSW, Australia
| | | | | |
Collapse
|
15
|
Gilligan P, Bhatarcharjee C, Knight G, Smith M, Hegarty D, Shenton A, Todd F, Bradley P. To lead or not to lead? Prospective controlled study of emergency nurses' provision of advanced life support team leadership. Emerg Med J 2005; 22:628-32. [PMID: 16113181 PMCID: PMC1726914 DOI: 10.1136/emj.2004.015321] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND AND OBJECTIVES In many emergency departments advanced life support (ALS) trained nurses do not assume a lead role in advanced resuscitation. This study investigated whether emergency nurses with previous ALS training provided good team leadership in a simulated cardiac arrest situation. METHODS A prospective study was conducted at five emergency departments and one nurses' association meeting. All participants went through the same scenario. Details recorded included baseline blood pressure and pulse rate, time in post, time of ALS training, and subjective stress score (1 = hardly stressed; 10 = extremely stressed). Scoring took into account scenario understanding, rhythm recognition, time to defibrillation, appropriateness of interventions, and theoretical knowledge. RESULTS Of 57 participants, 20 were ALS trained nurses, 19 were ALS trained emergency senior house officers (SHOs), and 18 were emergency SHOs without formal ALS training. The overall mean score for doctors without ALS training was 69.5%, compared with 72.3% for ALS trained doctors and 73.7% for ALS trained nurses. Nurses found the experience less stressful (subjective stress score 5.78/10) compared with doctors without ALS training (6.5/10). The mean time taken to defibrillate from the appearance of a shockable rhythm on the monitor by the nurses and those SHOs without ALS training was 42 and 40.8 seconds, respectively. CONCLUSION ALS trained nurses performed as well as ALS trained and non ALS trained emergency SHOs in a simulated cardiac arrest situation and had greater awareness of the potentially reversible causes of cardiac arrest. Thus if a senior or middle grade doctor is not available to lead the resuscitation team, it may be appropriate for experienced nursing staff with ALS training to act as ALS team leaders rather than SHOs.
Collapse
|
16
|
Abstract
We assessed the utility of the chest film as a screening tool for term and preterm neonates with suspected structural heart disease. Three independent observers, blinded to patient diagnosis, retrospectively evaluated the initial chest film for each of 128 consecutive neonates with suspected heart disease (gestational age, 23-42 weeks; birth weight, 500-4,621 g) who had undergone both chest radiography and echocardiography. These evaluations were subsequently compared with the results of the respective echocardiograms, read by board-certified pediatric cardiologists blinded to the chest film and chest film interpretation. Kappa statistics demonstrated moderate correlation (0.42-0.48) among different observers in their interpretation of the chest films but poor correlation (0.15-0.34) between chest radiography and echocardiography. The chest film had a low sensitivity for structural heart disease (26-59%), with a negative predictive value of 46-52%. Among neonates less than 2 kg or younger than 35 weeks of gestation, the chest film had still lower sensitivity for detecting heart disease. Despite agreement among observers in chest film interpretation, the chest film does not function as a screening test for neonates with suspected heart disease, particularly in small or premature neonates. In neonates with suspected heart disease, echocardiography should be considered, even in patients with chest films that do not suggest congenital heart disease.
Collapse
Affiliation(s)
- B Fonseca
- Department of Pediatrics, University of California, San Diego, UCSD Medical Center, 200 W. Arbor, CA 92103, USA
| | | | | | | | | |
Collapse
|
17
|
Cripps MC, Vincent M, Jonker D, Kerr I, Dingle B, Martin LA, Mathews J, Biagi J, Knight G, Lam W. Dose reduced first-line capecitabine monotherapy in older and less fit patients with advanced colorectal cancer (ACRC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.3577] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. C. Cripps
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - M. Vincent
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - D. Jonker
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - I. Kerr
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - B. Dingle
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - L. A. Martin
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - J. Mathews
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - J. Biagi
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - G. Knight
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| | - W. Lam
- Ottawa Hosp Regional Cancer Ctr, Ottawa, ON, Canada; London Health Sciences Ctr, London, ON, Canada; British Columbia Cancer Agency, Kelowna, BC, Canada; Windsor Regional Cancer Ctr, Windsor, ON, Canada; Kingston Regional Cancer Ctr, Kingston, ON, Canada; Grand River Regional Cancer Ctr, Kitchener, ON, Canada; British Columbia Community Oncology Trialists, Burnaby, BC, Canada
| |
Collapse
|
18
|
Emsley J, Knight G, Farndale R. Structure of the integrin a2b1 binding collagen peptide. Acta Crystallogr A 2004. [DOI: 10.1107/s010876730409676x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
19
|
Vincent MD, Jonker D, Kerr I, Goel R, Martin LA, Gurjal A, Mathews J, Biagi J, Knight G, Lam W. Prognostication using serum levels of components of the folate metabolic pathway in patients (PTS) treated with capecitabine for advanced colorectal cancer (ACRC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. D. Vincent
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - D. Jonker
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - I. Kerr
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - R. Goel
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - L. A. Martin
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - A. Gurjal
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - J. Mathews
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - J. Biagi
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - G. Knight
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| | - W. Lam
- London Regional Cancer Centre, London, ON, Canada; Ottawa Regional Cancer Centre, Ottawa, ON, Canada; British Columbia Cancer Agency, Surrey, BC, Canada; Windsor Regional Cancer Centre, Windsor, ON, Canada; Kingston Regional Cancer Centre, Kingston, ON, Canada; Grand River Regional Cancer Centre, Kitchener, ON, Canada; British Columbia Community Oncology Associates, Vancouver, BC, Canada
| |
Collapse
|
20
|
|
21
|
Knight G. Risks with continuous subcutaneous insulin infusion can be serious. BMJ 2001; 323:693-4. [PMID: 11566839 PMCID: PMC1121246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
22
|
|
23
|
|
24
|
|
25
|
Knight G. Clinicalfile. Shoulder dystocia. Pract Midwife 2001; 4:29. [PMID: 12026658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Affiliation(s)
- G Knight
- West Middlesex University Hospital
| |
Collapse
|
26
|
Quek LS, Pasquet JM, Hers I, Cornall R, Knight G, Barnes M, Hibbs ML, Dunn AR, Lowell CA, Watson SP. Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 2000; 96:4246-53. [PMID: 11110698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023] Open
Abstract
Activation of platelets by collagen is mediated by the complex glycoprotein VI (GPVI)/Fc receptor gamma (FcR gamma chain). In the current study, the role of 2 Src family kinases, Fyn and Lyn, in GPVI signaling has been examined using murine platelets deficient in one or both kinases. In the fyn(-/-) platelets, tyrosine phosphorylation of FcR gamma chain, phopholipase C (PLC) activity, aggregation, and secretion are reduced, though the time of onset of response is unchanged. In the lyn(-/-) platelets, there is a delay of up to 30 seconds in the onset of tyrosine phosphorylation and functional responses, followed by recovery of phosphorylation and potentiation of aggregation and alpha-granule secretion. Tyrosine phosphorylation and aggregation in response to stimulation by collagen-related peptide is further attenuated and delayed in fyn(-/-)lyn(-/-) double-mutant platelets, and potentiation is not seen. This study provides the first genetic evidence that Fyn and Lyn mediate FcR immune receptor tyrosine-based activation motif phosphorylation and PLC gamma 2 activation after the ligation of GPVI. Lyn plays an additional role in inhibiting platelet activation through an uncharacterized inhibitory pathway. (Blood. 2000;96:4246-4253)
Collapse
Affiliation(s)
- L S Quek
- Department of Pharmacology, University of Oxford, United Kingdom
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
BACKGROUND There are currently between 1 and 2 million breast cancer survivors in the United States. Is the advocated, early intervention the key to successful treatment, or are there other, more important factors? METHODS Responses to combined decongestive therapy (CDT) for 69 women were analyzed with regard to duration of lymphedema, differences in arm circumference, percent differences in arm volumes, volume of edema, reduction of edema volumes, and duration of treatment. RESULTS Two- and three-dimensional (2D and 3D) analyses showed little correlation between duration and volume of edema or between duration and response and treatment. However, they did show a correlation between initial volumes of fluid in the tissues and responses. Patients with initial volumes of 250 mL or less had a mean reduction of 78% with CDT, whereas those with initial volumes between 250 and 500 mL had a mean reduction of 56%. CONCLUSION The key to predicting successful lymphedema treatment is the initial volume of edema in the tissues regardless of whether the intervention is early or late.
Collapse
Affiliation(s)
- S M Ramos
- Department of Surgery, University of New Mexico School of Medicine, HealthSouth-Albuquerque Lymphedema Treatment Program, New Mexico, USA
| | | | | |
Collapse
|
28
|
Saitongdee P, Milner P, Loesch A, Knight G, Burnstock G. Electron-immunocytochemical studies of perivascular nerves of mesenteric and renal arteries of golden hamsters during and after arousal from hibernation. J Anat 1999; 195 ( Pt 1):121-30. [PMID: 10473299 PMCID: PMC1467971 DOI: 10.1046/j.1469-7580.1999.19510121.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Electron immunocytochemistry was used to examine perivascular nerves of hamster mesenteric and renal arteries during hibernation and 2 h after arousal from hibernation. Vessels from cold-exposed but nonhibernating, and normothermic control hamsters were also examined. During hibernation the percentage of axon profiles in mesenteric and renal arteries that were immunopositive for markers of sympathetic nerves, tyrosine hydroxylase (TH) and neuropeptide Y (NPY), were increased 2-3 fold compared with normothermic and cold control animals. This increase was reduced markedly only 2 h after arousal from hibernation. The small percentage of nitric oxide synthase-1-positive axon profiles found in mesenteric (but not renal) arteries was also increased during hibernation and returned towards control values after arousal. In contrast, the percentage of perivascular axons immunostaining for vasoactive intestinal polypeptide (VIP), a marker for parasympathetic nerves, was reduced in mesenteric arteries during hibernation. There was no labelling of perivascular nerves for substance P in either mesenteric or renal arteries. It is suggested that the increase in percentage of TH- and NPY-immunostained perivascular nerves may account for the increased vasoconstriction associated with high vascular resistance that is known to occur during hibernation. The reduction in the percentage of axons positive for VIP in hibernating animals would contribute to this mechanism since this neuropeptide is a vasodilator.
Collapse
Affiliation(s)
- P Saitongdee
- Department of Anatomy and Developmental Biology, University College London, UK
| | | | | | | | | |
Collapse
|
29
|
Saitongdee P, Loesch A, Knight G, Milner P, Burnstock G. Ultrastructural localization of nitric oxide synthase and endothelin in the renal and mesenteric arteries of the golden hamster: differences during and after arousal from hibernation. Endothelium 1999; 6:197-207. [PMID: 10365771 DOI: 10.3109/10623329909053410] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
This is a study of the electron-immunocytochemical localization of nitric oxide synthase (type III) and endothelin in renal and mesenteric artery endothelial cells of normal (active) and hibernating hamsters, as well as hamsters exposed to the cold but not hibernating, and hamsters aroused for 2h following hibernation. In the renal artery of hibernating hamsters and cold-exposed hamsters, a subpopulation of nitric oxide synthase-positive endothelial cells displayed immunoprecipitate predominantly in the vicinity of the Golgi complex indicating intracellular translocation from the cytoplasm to the Golgi complex. In hibernating animals, the percentages of both nitric oxide synthase-positive and endothelin-positive endothelial cells were notably lower than those observed either in active, cold-exposed or aroused animals. These changes may reflect a reduced endothelial contribution to the maintenance of vascular tone in these vessels during hibernation and an upregulation of expression of nitric oxide synthase and endothelin in the endothelium early on during arousal from hibernation.
Collapse
Affiliation(s)
- P Saitongdee
- Department of Anatomy and Developmental Biology and Centre for Neuroscience, University College London, UK
| | | | | | | | | |
Collapse
|
30
|
Abstract
Children spend a large part of their school days in the classroom, and yet the effect of the design of school furniture on their behaviour and health has received comparatively little attention in the UK. An experimental study is reported that compares the effects on children's behaviour and sitting position of traditional classroom furniture with a recently designed chair known as 'Chair 2000' and associated tables. It was found that children showed a modest but significant improvement in on-task behaviour and a marked change in sitting positions following the introduction of the newly-designed furniture. However, these benefits need to be considered in the light of polarized opinion for and against the new furniture, and a high level of reported incidence of back pain significantly related to the frequency of non-standard sitting. In the absence of radically redesigned furniture, it is suggested that children should be given more choice in their seating, and better guidance should be given to individuals involved in education in order to inform their decision-making about classroom furniture and the postural, anthropometric and orthopaedic aspects of sitting and related activities.
Collapse
Affiliation(s)
- G Knight
- School of Education, University of Birmingham, UK
| | | |
Collapse
|
31
|
Ralevic V, Knight G, Burnstock G. Effects of hibernation and arousal from hibernation on mesenteric arterial responses of the golden hamster. J Pharmacol Exp Ther 1998; 287:521-6. [PMID: 9808676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023] Open
Abstract
The aim of our study was to investigate the changes that occur in functional responses of the golden hamster mesenteric arterial bed after: 1) 8 wk of hibernation and 2) 2 hr after arousal from hibernation. Age-matched and cold-exposed hamsters were used as controls. At 8 wk after hibernation there was an increase in sensitivity of vasoconstrictor responses to sympathetic nerve stimulation but no significant difference in constrictor responses to norepinephrine, alpha,beta-methylene ATP, uridine 5'-triphosphate or KCl (studied in unconstricted preparations), or in endothelium-dependent vasodilatation to acetylcholine and uridine 5'-triphosphate (in methoxamine-preconstricted preparations) compared with the control groups. In contrast, in the arousal from hibernation group, sympathetic vasoconstriction was similar to that in the control groups, and the maximal response to exogenous norepinephrine, and responses to alpha,beta-methylene ATP were augmented. These results suggest that there is an augmentation of sympathetic neurotransmission of golden hamster mesenteric arteries at 8 wk after hibernation, which appears to be due to pre- rather than postjunctional changes. This is reversed with arousal from hibernation, when the sensitivity of sympathetic contractile responses is not different from that of the controls. However, an increase in maximal constrictor responses to norepinephrine suggests that postjunctional changes may occur in sympathetic neurotransmission during arousal.
Collapse
Affiliation(s)
- V Ralevic
- Autonomic Neuroscience Institute, Royal Free Hospital School of Medicine, London NW3 2PF, England
| | | | | |
Collapse
|
32
|
Karoon P, Knight G, Burnstock G. Enhanced vasoconstrictor responses in renal and femoral arteries of the golden hamster during hibernation. J Physiol 1998; 512 ( Pt 3):927-38. [PMID: 9769433 PMCID: PMC2231249 DOI: 10.1111/j.1469-7793.1998.927bd.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/1997] [Accepted: 07/29/1998] [Indexed: 11/27/2022] Open
Abstract
1. The present study assessed local regulation of vascular tone of euthermic (control), cold control and hibernating golden hamsters. Sympathetic neurotransmission in the renal artery, the long term effects of hibernation on perivascular nerve activity, and the responsiveness of femoral artery to a number of neurotransmitters and hormones with both constrictor and dilator actions during hibernation are described. 2. The contractile responses of the renal arterial rings to transmural nerve stimulation (80 V, 0.1 ms, 4-64 Hz, for 1 s) were negligible in controls, significantly increased at higher frequencies of stimulation in cold controls and markedly enhanced in the hibernating group at all frequencies tested. The contractile responses to exogenous noradrenaline (NA; 0.1-100 microM) were significantly increased in the renal arteries of hibernating hamsters compared with controls, but not compared with cold controls. Responses to exogenous ATP (1-3000 microM) and KCl (120 mM) were similar among all experimental groups. 3. The maximal contractile responses of femoral arterial rings to the sympathetic co-transmitter ATP and 5-hydroxytryptamine were increased by approximately 124% and 99%, respectively, in hibernating compared with cold control preparations without a change in the concentration of agonist that produces half-maximal response. However, the responses to NA were not altered during hibernation. 4. Vasoconstriction of femoral arterial rings in response to arginine vasopressin was significantly enhanced in both cold controls and hibernating groups, while vasoconstriction in response to endothelin-1 and KCl was unaltered. 5. The dilator responses of femoral arterial rings to acetylcholine, sodium nitroprusside and adenosine were not different among the groups. 6. It is suggested that the marked augmentation of sympathetic neurotransmission, selective supersensitivity of the vascular smooth muscle to sympathetic contractile agents and unaltered vasodilatory mechanisms may provide a means for maintenance of vascular tone and peripheral resistance during hibernation.
Collapse
Affiliation(s)
- P Karoon
- Department of Anatomy and Developmental Biology and Centre for Neuroscience, University College London, Gower Street, London WC1E 6BT, UK
| | | | | |
Collapse
|
33
|
Crandall BF, Corson VL, Evans MI, Goldberg JD, Knight G, Salafsky IS. American College of Medical Genetics statement on folic acid: fortification and supplementation. Am J Med Genet 1998; 78:381. [PMID: 9714444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
34
|
Ralevic V, Hill B, Crowe R, Knight G, Burnstock G. Effects of hibernation on neural and endothelial control of mesenteric arteries of the golden hamster. Am J Physiol 1997; 273:H148-55. [PMID: 9249485 DOI: 10.1152/ajpheart.1997.273.1.h148] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The effects of hibernation on mesenteric arterial innervation and function were examined using pharmacological and immunohistochemical techniques in age-matched controls, cold-exposed controls, and 4-wk-hibernated golden hamsters. Electrical field stimulation of the isolated mesenteric arterial bed elicited frequency-dependent vasoconstriction. The sensitivity of responses was significantly increased in tissues from hibernating animals compared with cold-exposed controls. Vasoconstrictor responses to exogenous norepinephrine were also increased in hibernation. However, there was a significant decrease in sensitivity of vasoconstriction to ATP in hibernated and cold-exposed tissue compared with age-matched controls. In preparations preconstricted with methoxamine, endothelium-dependent vasodilator responses to acetylcholine and ATP were similar among the groups. Immunohistochemical investigation of mesenteric arteries revealed no differences among the groups in density of innervation by nerves immunoreactive for tyrosine hydroxylase, neuropeptide Y, and calcitonin gene-related peptide. Postjunctional changes appear to occur in hibernation, leading to augmentation of sympathetic vasoconstriction, which is consistent with the increase in peripheral vascular resistance in hibernation. Endothelium-dependent vasodilatation is not significantly changed in hibernation in the hamster mesenteric arterial bed.
Collapse
Affiliation(s)
- V Ralevic
- Department of Anatomy and Developmental Biology, University College London, United Kingdom
| | | | | | | | | |
Collapse
|
35
|
Shochina M, Belai A, Toole L, Knight G, Burnstock G. Neurochemical coding in the myenteric plexus of the upper gastrointestinal tract of hibernating hamsters. Int J Dev Neurosci 1997; 15:353-62. [PMID: 9253659 DOI: 10.1016/s0736-5748(97)00003-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
As part of our investigation of the plasticity of autonomic nerves in physiological and pathological conditions, we have examined the effect of hibernation on the neurochemical content of myenteric nerves and nerve cell bodies of the upper gastrointestinal tract of the non-seasonal hibernator, the golden hamster. Age matched hamsters kept at room temperature and those kept at 5 degrees C but which failed to hibernate, were used as controls. Possible changes in nerve fibres and nerve cell bodies containing the general neuronal marker, protein gene product 9.5, the peptides, vasoactive intestinal polypeptide, substance P (SP) and calcitonin gene-related peptide (CGRP), the catecholamine synthesizing enzyme tyrosine hydroxylase and the enzyme responsible for synthesizing nitric oxide, nitric oxide synthase, were examined in the oesophagus, proventriculus and proximal and distal stomach of the golden hamsters using immunohistochemical techniques. The results of the present study revealed a significant increase in the number of nerve cell bodies and density of nerve fibres containing SP-immunoreactivity and increased number of CGRP-immunoreactive cell bodies but not the other markers examined in the proximal stomach and proventriculus. In contrast, there was no change in the distribution of any of the neuroactive substances examined in the myenteric plexus of the oesophagus and distal stomach. It is suggested that the change in the environment of the hibernating hamsters perturbs the normal digestive physiology in the proximal stomach and proventriculus that is reflected by the selective changes in SP- and CGRP-containing enteric nerves; these changes may be part of protective reflex mechanisms to the environmental changes resulting from hibernation, where upgrading of nerve cell bodies expressing CGRP and SP has occurred.
Collapse
Affiliation(s)
- M Shochina
- Rehabilitation Department, Hadassah University Hospital, Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | | | | | | | | |
Collapse
|
36
|
Heggie JR, Wu M, Burns RB, Ng CS, Fung HC, Knight G, Barnett MJ, Spinelli JJ, Embree L. Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan. J Chromatogr B Biomed Sci Appl 1997; 692:437-44. [PMID: 9188834 DOI: 10.1016/s0378-4347(96)00520-8] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The development and validation of a high-performance liquid chromatographic (HPLC) assay for determination of busulfan concentrations in human plasma for pharmacokinetic studies is described. Plasma samples containing busulfan and 1,6-bis(methanesulfonyloxy)hexane, and internal standard, were prepared by derivatization with sodium diethyldithiocarbamate (DDTC) followed by addition of methanol and extraction with ethyl acetate. The extract was dried under nitrogen and the samples reconstituted with 100 microl of methanol prior to HPLC determination. Chromatography was accomplished using a Waters NovaPak octadecylsilyl (ODS) (150 x 3.9 mm I.D.) analytical column, NovaPak ODS guard column, and mobile phase of methanol-water (80:20, v/v) at a flow-rate of 0.8 ml/min with UV detection at 251 nm. The limit of detection was 0.0200 microg/ml (signal-to-noise ratio of 6) with a limit of quantitation (LOQ) of 0.0600 microg/ml for busulfan in plasma. Calibration curves were linear from 0.0600 to 3.00 microg/ml in plasma (500 microl) using a 1/y weighting scheme. Precision of the assay, as represented by C.V. of the observed peak area ratio values, ranged from 4.41 to 13.5% (13.5% at LOQ). No day-to-day variability was observed in predicted concentration values and the bias was low for all concentrations evaluated (bias: 0 to 4.76%; LOQ: 2.91%). The mean derivatization and extraction yield observed for busulfan in plasma at 0.200, 1.20 and 2.00 microg/ml was 98.5% (range 93.4 to 107%). Plasma samples containing potential busulfan metabolites and co-administered drugs, which may be present in clinical samples, provided no response indicating this assay procedure is selective for busulfan. This method was used to analyze plasma concentrations following administration of a 1 mg/kg oral busulfan dose.
Collapse
Affiliation(s)
- J R Heggie
- Advanced Therapeutics, Division of Medical Oncology, British Columbia (BC) Cancer Agency, Vancouver, Canada
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Abstract
Solutions of gamma-crystallin, and various enzymes, at neutral pH and 24-26 degrees C, became turbid upon exposure to UV radiation at 295 or 308 nm. SDS-PAGE analysis revealed interchain cross-linking and aggregate formation compared to dark control solutions as reported previously. When alpha-crystallin was added to the protein solutions in stoichiometric amounts, UV irradiation resulted in significantly less turbidity than in the absence of alpha-crystallin. For example, addition of 0.5 mg of alpha-crystallin to 0.5 mg of gamma-crystallin in 1.0 ml solution yielded only 25% of the turbidity seen in the absence of alpha-crystallin. Addition of 2.0 mg of alpha-crystallin resulted in 20% of the turbidity. Given the molecular weights of alpha- and gamma-crystallin (about 800 kDa and 20 kDa, respectively), a gamma/alpha 1:1 weight ratio corresponds to a 40:1 molar ratio, and a gamma/alpha 1:4 weight ratio corresponds to a 10:1 molar ratio. Hence, the molar ratio of alpha-crystallin needed to effectively protect gamma-crystallin from photochemical opacification was gamma/alpha = n:1, where n was in the range 10-40. In terms of subunits, this ratio is gamma/alpha = 1:m, where m = 1-4. Thus, each gamma-crystallin molecule needs 1-4 alpha subunits for protection. Similar stoichiometries were observed for protection of the other proteins studied. The protection stems in part from screening of UV radiation by alpha-crystallin but more importantly from a chaperone effect analogous to that seen in thermal aggregation experiments.
Collapse
Affiliation(s)
- R F Borkman
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta 30332, USA
| | | | | |
Collapse
|
38
|
Abstract
The cDNA of a novel matrix metalloproteinase, collagenase-3 (MMP-13) has been isolated from a breast tumor library (Freije, J. M. P., Dicz-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J., and López-Otin, C. (1994) J. Biol. Chem. 269, 16766-16773), and a potential role in tumor progression has been proposed for this enzyme. In order to establish the possible role of collagenase-3 in connective tissue turnover, we have expressed and purified recombinant human procollagenase-3 and characterized the enzyme biochemically. The purified procollagenase-3 was shown to be glycosylated and displayed a M(r) of 60,000, the N-terminal sequence being LPLPSGGD, which is consistent with the cDNA-predicted sequence. The proenzyme was activated by p-aminophenylmercuric acetate or stromelysin, yielding an intermediate form of M(r) 50,000, which displayed the N-terminal sequence L58EVTGK. Further processing resulted in cleavage of the Glu84-Tyr85 peptide bond to the final active enzyme (M(r) 48,000). Trypsin activation of procollagenase-3 also generated a Tyr85 N terminus, but it was evident that the C-terminal domain was rapidly lost, and hence the collagenolytic activity diminished. Analysis of the substrate specificity of collagenase-3 revealed that soluble type II collagen was preferentially hydrolyzed, while the enzyme was 5 or 6 times less efficient at cleaving type I or III collagen. Fibrillar type I collagen was cleaved with comparable efficiency to the fibroblast and neutrophil collagenases (MMP-1 and MMP-8), respectively. Unlike these collagenases, gelatin and the peptide substrates Mea-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 and Mca-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 were efficiently hydrolyzed as well, as would be predicted from the similarities between the active site sequence of collagenase-3 (MMP-13) and the gelatinases A and B. Active collagenase-3 was inhibited in a 1:1 stoichiometric fashion by the tissue inhibitors of metalloproteinases, TIMP-1, TIMP-2, and TIMP-3. These results suggest that in vivo collagenase-3 could play a significant role in the turnover of connective tissue matrix constituents.
Collapse
Affiliation(s)
- V Knäuper
- Strangeways Research Laboratory, Department of Cell and Molecular Biology, Worts' Causeway, Cambridge, United Kingdom
| | | | | | | | | |
Collapse
|
39
|
Wald NJ, Kennard A, Watt H, Haddow JE, Palomaki GE, Knight G, Canick JA. Decision analysis and screening for Down's syndrome. Testing should be in all women. BMJ 1995; 311:1372-3. [PMID: 7496310 PMCID: PMC2551272 DOI: 10.1136/bmj.311.7016.1372a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
40
|
Affiliation(s)
- B F Crandall
- Department of Psychiatry and Pediatrics, University of California Los Angeles 90024, USA
| | | | | | | | | |
Collapse
|
41
|
Abstract
The aim of this study was to evaluate, with the aid of a questionnaire distributed to selected groups of dentists, the use of glass ionomer cement in different types of proximal restorations and further to evaluate any complications observed with the use of GIC. Few dentists responded in the 'Often' category regarding the observation of secondary caries or gingival inflammation in association with GIC fillings compared with about three-quarters of the dentists who reported on posterior composite resin restorations. Tunnel cavities had been prepared and restored by 54 per cent of the dentists, simple proximal restorations in primary molars by 89 per cent and 'sandwich' restorations by 69 per cent. Few dentists with at least two years experience with tunnel restorations observed biological complications, but fracture of the marginal ridge was reported in the 'Often' category by 12 per cent. Among the dentists with at least five years experience with proximal restorations in primary molars 59 per cent of the operators mentioned more complications with these than with amalgam restorations. Biological complications were not a great problem with glass ionomer/composite laminates but wear or dissolution of the proximal GIC surface was recorded in the 'Often' section by 14 per cent of those placing them.
Collapse
Affiliation(s)
- L Forsten
- Department of Cariology, University of Turku, Finland
| | | | | |
Collapse
|
42
|
|
43
|
Knight G. Using technology to reduce the costs of dentistry. FDI World 1994; 3:10-2. [PMID: 9552697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
44
|
Knight G. Book Review: Sedation and Analgesia. Anaesth Intensive Care 1994. [DOI: 10.1177/0310057x9402200321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- G. Knight
- Princess Margaret Hospital Perth, W.A
| |
Collapse
|
45
|
Knight G. Aesthetic landmarks--guidelines of reality and illusion. Dent World 1992:11-3. [PMID: 1290947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
46
|
Knight G, Anthony TH. Orthodontic soldering. Trends Tech Contemp Dent Lab 1991; 8:43-6. [PMID: 1682989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- G Knight
- University of Texas Health Science Center at San Antonio
| | | |
Collapse
|
47
|
Knight G. Development of impactor size-selective dust samplers at the Elliot Lake Laboratory. Am Ind Hyg Assoc J 1991; 52:164-71. [PMID: 2069124 DOI: 10.1080/15298669191364523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The Elliot Lake Laboratory designs and uses impactor size selectors for respirable and other dust samplers both in the laboratory and in mines. Advantages of the selectors are compact size, reproducibility of size-selection performance based on the high precision of drill manufacture and use, flexibility in design and layout, and manufacturing ease in a machine shop. The major problems in design and performance were secondary deposition of dust and overloading with coarse dust. Secondary deposition modified the calculated size selection and either limited the spacing between adjacent orifices or orifices and other features or required a final calibration. Overloading of the coarse dust deposition zone led to changes in size-selection characteristics as the dust load increased, giving a definite limit to acceptable dust collection quantities. The use of multiple stages increased the coarse dust-holding capability manyfold. All the dust samplers developed at the Elliot Lake Laboratory used two or more successive stages to increase dust-holding capacity.
Collapse
Affiliation(s)
- G Knight
- Elliot Lake Laboratory, CANMET, Ontario, Canada
| |
Collapse
|
48
|
O'Brien ME, Eccles DM, Allen SG, Knight G, Rodger A, Chetty U, Smyth JF, Leonard RC. Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity. Cancer Chemother Pharmacol 1991; 28:402-4. [PMID: 1914086 DOI: 10.1007/bf00685697] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The combination of mitozantrone and prednimustine has been reported to elicit response rates of around 50% in patients with advanced breast cancer. In the present trial, either three or nine courses of this combination were given to previously untreated patients with advanced breast cancer. Mitozantrone was given at 12 mg/m2 on day 1 and prednimustine was given orally at 130 mg/m2 on days 1-5; treatment was repeated every 4 weeks. A total of 34 patients were treated; the performance status was 0-1 in 29 subjects and 2 in 5 cases. Locoregional disease only was present in 13 patients; 9 showed lung involvement; 8, liver; 3, bone; and 1, stomach involvement. A total of 10 subjects had received no prior hormone therapy. The median disease-free interval from the time of initial diagnosis was 24 months (range, 0-144 months). In all 14/23 patients exhibited an oestrogen receptor level of greater than 20 fmol. Grade 1 nausea and vomiting occurred in 16 patients and that of grade 2-3, in 11 subjects; nausea was prolonged for greater than 10 days in 7 cases. Grade 4 neutropenia occurred in 2 patients. The response rate was 21% (95% confidence interval, 8%-38%). The combination of mitozantrone and oral prednimustine is toxic and displays low activity.
Collapse
Affiliation(s)
- M E O'Brien
- Imperial Cancer Research Fund Medical Oncology Unit, University Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland, UK
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
Two series of pregnancies were studied to investigate the relationship between maternal smoking and the risk of fetal Down's syndrome. In the first series, ascertained in the 1960s, in which smoking habits were determined after the outcome of pregnancy was known, the proportion of smokers (47 per cent) among the 461 women whose pregnancies ended in the birth of an infant with Down's syndrome was similar to that in the 461 controls (46 per cent) who had pregnancies affected by other congenital disorders. In the second series, ascertained between 1973 and 1984, smoking habits were determined by measurement of cotinine in antenatal serum samples that were routinely collected and stored or, if a serum sample was not available, from information in the antenatal notes. In this series, the proportion of smokers (14 per cent) among the 91 women who had pregnancies associated with Down's syndrome was lower than that among 413 controls (19 per cent), though this was not statistically significant. Collectively, our results provide no evidence for an association between fetal Down's syndrome and smoking. Other published studies found a deficit of smokers among women who had pregnancies associated with Down's syndrome. This may be partly due to some studies not taking adequate account of maternal age (older women are more likely to have had a Down's syndrome pregnancy but are less likely to be smokers) and partly due to the greater tendency for positive findings to be published than negative ones.
Collapse
Affiliation(s)
- H S Cuckle
- Department of Environmental and Preventive Medicine, St. Bartholomew's Hospital Medical College, London, U.K
| | | | | | | | | |
Collapse
|
50
|
Zeman A, Knight G, Cullen DR. Papilloedema and diabetes mellitus. Diabet Med 1990; 7:465-6. [PMID: 2142048 DOI: 10.1111/j.1464-5491.1990.tb01424.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|